C Stancu
Overview
Explore the profile of C Stancu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
32
Citations
359
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Botezatu A, Vladoiu S, Fudulu A, Albulescu A, Plesa A, Muresan A, et al.
Biol Reprod
. 2022 May;
107(3):684-704.
PMID: 35594455
In the recent years a special attention has been given to a major health concern namely to male infertility, defined as the inability to conceive after 12 months of regular...
2.
Stancu C, Coculescu M
J Med Life
. 2015 Apr;
7 Spec No. 3:87-94.
PMID: 25870702
Background: Colocalization analysis of confocal fluorescence and electron microscopy (EM) are important tools to detect the expression of multiple anterior pituitary hormones within the same cell. Heterozygous (Men1+/-) mice developed...
3.
Sima A, Stancu C, Constantinescu E, Ologeanu L, Simionescu M
J Cell Mol Med
. 2002 Jun;
5(2):153-62.
PMID: 12067498
Male Golden Syrian hamsters were subjected to a hyperlipemic diet. At intervals ranging from 2 to 14 weeks, the animals were examined for changes in serum constituents and structural modifications...
4.
Niculescu L, Stancu C, Sima A, Toporan D, Simionescu M
J Cell Mol Med
. 2002 Jun;
5(3):285-94.
PMID: 12067487
Lipid peroxides were identified among the factors that contribute to the atherosclerotic plaque formation in the arterial wall. We hypothesised that a correlation may exist between the content of antioxidant...
5.
Stancu C, Sima A
J Cell Mol Med
. 2002 Jun;
5(4):378-87.
PMID: 12067471
The beneficial effects of statins are the result of their capacity to reduce cholesterol biosyntesis, mainly in the liver, where they are selectively distributed, as well as to the modulation...
6.
Sima A, Popov D, Starodub O, Stancu C, Cristea C, Stern D, et al.
Lab Invest
. 1997 Jul;
77(1):3-18.
PMID: 9251674
Diabetes is known to be accompanied by atherosclerotic disease and general cardiovascular complications. Hamsters were previously shown to develop hyperlipemia-induced atherosclerosis, similar in many respects to the human atherosclerotic process....
7.
Sima A, Stancu C, Starodub O, Cristea C, Simionescu M
Rom J Intern Med
. 1997 Jan;
35(1-4):29-38.
PMID: 9562650
Data from literature indicate that immune processes play an important role in atherogenesis. Modified lipoproteins might be immunogenic and generate autoantibodies in plasma. To determine whether the level of such...
8.
Simionescu M, Popov D, Sima A, Hasu M, Costache G, Faitar S, et al.
Am J Pathol
. 1996 Mar;
148(3):997-1014.
PMID: 8774154
Because accelerated atherosclerosis is the main complication of diabetes, we devised a new animal model that combines these two diseases, and investigated their joint impact on the main plasma components...
9.
Sima A, Hobai I, Stancu C, Cinteza M, GHERASIM L
Rom J Intern Med
. 1996 Jan;
34(1-2):55-64.
PMID: 8908631
We investigated the presence of biochemically modified plasma lipoproteins as pathologic factor for coronary heart disease in 15 patients with angina pectoris (CHD-P) vs 20 normal subjects (N). Decreased HDL...
10.
Stancu C, Stancu P, Lungulescu I
Med Interne
. 1985 Jul;
23(3):223-7.
PMID: 2864737
Serum gamma-glutamyltranspeptidase (GGTP) and alpha-amylase clearance were determined in a total group of 90 patients of whom 60 with renal diseases and 30 with extrarenal diseases. The renal patients were...